Current status and progress of health economics research on allergen specific immunotherapy.

Qianxue HU; Liyue LI; Ziyi LONG; Bingyue HUO; Yuzhe HAO; Xiangning CHENG; Tianjian XIE; Qing CHENG; Tao ZHOU; Liuqing ZHOU; Shan CHEN; Yue ZHOU; Jianjun CHEN

Return

Current status and progress of health economics research on allergen specific immunotherapy.

Author: Qianxue HU ¹ ; Liyue LI ¹ ; Ziyi LONG ¹ ; Bingyue HUO ¹ ; Yuzhe HAO ¹ ; Xiangning CHENG ¹ ; Tianjian XIE ¹ ; Qing CHENG ¹ ; Tao ZHOU ¹ ; Liuqing ZHOU ¹ ; Shan CHEN ¹ ; Yue ZHOU ¹ ; Jianjun CHEN ¹
Author Information

1. Department of Otolaryngology Head and Neck Surgery，Tongji Medical College Affiliated Union Hospital，Huazhong University of Science and Technology，Wuhan，430022，China.
Publication Type:English Abstract
Keywords: allergen immunotherapy; allergic rhinitis; health economics
MeSH: Humans; Desensitization, Immunologic/economics*; Cost-Benefit Analysis; Rhinitis, Allergic/economics*; Economics, Medical
From: Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2025;39(9):894-898
CountryChina
Language:Chinese
Abstract: Allergen specific immunotherapy（AIT）, as an effective treatment for allergic rhinitis, asthma, and other allergic diseases, has received widespread attention in the field of health economic evaluation in recent years. This article reviews the current status and progress of economic research on AIT, mainly discussing the socioeconomic burden of allergic rhinitis, the results of health economic studies from different countries, and the primary methods used in health economic research on allergic rhinitis. Existing studies indicate that, although AIT involves high initial costs, it offers significant long-term economic benefits by reducing healthcare resource utilization, improving patient quality of life, and decreasing medication dependence. Moreover, reducing initial costs, applying standardized assessment tools, and conducting cross-national comparative analyses have become key directions for future research. Overall, AIT demonstrates strong potential in terms of long-term health benefits and cost savings, providing solid economic evidence for the management of allergic diseases.